American BriVision (Holding) Corp License Agreements
16 Contracts & Agreements
- Amendment to the License Agreement between BioLite, Inc. and AiBtl BioPharma Inc (Filed With SEC on June 25, 2024)
- Amendment to the License Agreement between the Company and AiBtl BioPharma Inc (Filed With SEC on June 25, 2024)
- Amendment to the Definitive License Agreement between BIOFIRST CORPORATION and ForSeeCon Eye Corporation (Filed With SEC on June 24, 2024)
- Amendment to the Definitive License Agreement between the Company and ForSeeCon Eye Corporation (Filed With SEC on June 24, 2024)
- Definitive License Agreement between Biolite, Inc. and OncoX BioPharma, Inc. dated May 23, 2024 (Filed With SEC on May 24, 2024)
- Definitive License Agreement between the Company and OncoX BioPharma, Inc. May 23, 2024 (Filed With SEC on May 24, 2024)
- Definitive License Agreement between Rgene and OncoX BioPharma, Inc. dated May 8, 2024 (Filed With SEC on May 9, 2024)
- Definitive License Agreement between the Company and OncoX BioPharma, Inc. May 8, 2024 (Filed With SEC on May 9, 2024)
- Definitive License Agreement between Rgene and OncoX BioPharma, Inc (Filed With SEC on April 17, 2024)
- Definitive License Agreement between the Company and OncoX BioPharma, Inc (Filed With SEC on April 17, 2024)
- Definitive License Agreement between BIOFIRST CORPORATION and ForSeeCon Eye Corporation (Filed With SEC on March 26, 2024)
- Definitive License Agreement between the Company and ForSeeCon Eye Corporation (Filed With SEC on March 26, 2024)
- License Agreement between the BioLite and AiBtl BioPharma, Inc (Filed With SEC on November 15, 2023)
- License Agreement between the Company and AiBtl BioPharma, Inc (Filed With SEC on November 15, 2023)
- License Agreement with Red Spot Paint & Varnish Co (Filed With SEC on July 30, 2007)
- License Agreement with E.I. Du Pont De Nemours and Company (Filed With SEC on July 30, 2007)